Professor Sir Mark Caulfield, one of many nation’s most imminent scientists, is to depart his function at Genomics England to take up a brand new place as chief government at Barts Life Sciences.
Professor Caulfield joined Genomics England in 2013, the place he was tasked with main the scientific oversight and supply of the 100,000 Genomes Mission, which ran till 2018. His work right here led to a analysis useful resource – the most important of its form wherever on this planet – that’s serving to to additional the usage of genomics in healthcare. He was awarded a knighthood in 2019, and England’s genomics trade is now recognised as world-leading.
Extra just lately Professor Caulfield has labored with NHS England to create the Nationwide Genomic Check Listing and the NHS Genomic Medication Service to supply equitable entry for 56million individuals to applicable genomics assessments.
Genomics is anticipated to play an integral a part of healthcare’s evolution – earlier this 12 months Man’s and St Thomas’ NHS Basis Belief introduced a web based programme to show workers about genomics.
Chris Wigley, CEO of Genomics England, mentioned: “Mark leaves a unprecedented legacy of scientific achievement right here for his successor and the broader workforce to construct upon… The UK continues to guide the world in genomic medication, which is partly attributable to Mark’s vital contribution. We’re very a lot wanting ahead to seeing how he will get on at Barts and want him properly shifting ahead.”
Barts is a analysis and innovation partnership between Queen Mary College of London and Barts Well being NHS Belief. Professor Caulfield shall be main the event of a world-leading life sciences campus at Whitechapel when he steps into his new function on the finish of the month.
However Professor Caulfield gained’t be leaving genomics behind. His new function at Barts may have a concentrate on the science, in addition to digital well being and scientific innovation with a purpose to rework the supply of healthcare.